Cargando…
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Liquid biopsy refers to the analysis of any tumour-derived material circulating in the blood or any other body fluid. This concept is particularly relevant in lung cancer as the tumour is often difficult to reach and may need an invasive and potentially harmful procedure. Moreover, the multitude of...
Autores principales: | Guibert, Nicolas, Pradines, Anne, Favre, Gilles, Mazieres, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488537/ https://www.ncbi.nlm.nih.gov/pubmed/32051167 http://dx.doi.org/10.1183/16000617.0052-2019 |
Ejemplares similares
-
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!
por: Durin, Lucile, et al.
Publicado: (2020) -
Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma
por: Guibert, Nicolas, et al.
Publicado: (2017) -
Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges
por: Ulrich, Bryan, et al.
Publicado: (2021) -
Early Steps of Resistance to Targeted Therapies in Non-Small-Cell Lung Cancer
por: Delahaye, Celia, et al.
Publicado: (2022) -
Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications
por: Vandekerckhove, Olivia, et al.
Publicado: (2023)